◀ Back to NAB2
IFNB1 — NAB2
Text-mined interactions from Literome
Bertolotto et al., Neurology 2003
(Multiple Sclerosis) :
Every 3 months,
IFNbeta induced
neutralizing antibodies ( NAb ) were evaluated in sera using a cytopathic effect assay
Chiu et al., Clin Exp Immunol 2007
(Multiple Sclerosis, Relapsing-Remitting) :
In the present study, we describe the
effect of
NAb on
IFN-beta-1b through clinical and magnetic resonance imaging ( MRI ) outcome measures of five relapsing remitting multiple sclerosis ( RRMS ) patients who were treated with 250 mug of subcutaneously administered IFN-beta-1b every other day and developed NAb at varying titres and times during the course of therapy